Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Sector Allocation
- Financials27.8%$94.3M
- Healthcare25.1%$85.3M
- Technology20.1%$68.4M
- Industrials8.8%$29.8M
- Utilities7.5%$25.4M
- Energy7.2%$24.6M
- Other3.2%$11.0M
- Consumer Discretionary0.1%$419,902
- Consumer Staples0.1%$252,862
- Materials0.1%$213,269
AUM History
13fpro.ai/research/fund/arrowpoint-investment-partners-singapore-pte-ltd-2032331
Conviction and streaks
Concentrating · top 10 = 63.9%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
C
$32.9MGS
$31.3MGPN
$27.9MNSC
$25.6MAEP
$25.4MNVDA
$25.1MXOM.R34088
$24.5MGOOGL
$12.3MMU
$7.5MINTC
$4.7MSNDK
$4.6MARGX
$4.1MINFY
$3.9MCAT
$3.8MAXSM
$3.4MINSM
$3.2MUNH
$3.2MBRKR
$3.2MMDGL
$3.1MTVTX
$3.1M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/arrowpoint-investment-partners-singapore-pte-ltd-2032331
Arrowpoint Investment Partners (Singapore) Pte. Ltd. 13F holdings — Q2 2026
$459.0M portfolio (+308.0% QoQ) · 129 holdings · Q2 2026 13F · top 10 are 64% of the stock portfolio
Includes $119.1M of put/call options ($29.5M puts, $89.6M calls), which 13F rules report at the value of the underlying shares, not the premium at risk. Stocks alone: $339.9M. Weights use the stock portfolio.
$32.9M
9.7% of stocks
NewThis quarter-12.8%Since filedNew this quarterHeld$31.3M
9.2% of stocks
NewThis quarter-14.3%Since filedNew this quarterHeld$27.9M
8.2% of stocks
NewThis quarter-13.7%Since filedNew this quarterHeld$25.6M
7.5% of stocks
NewThis quarter-1.1%Since filedNew this quarterHeld$25.4M
7.5% of stocks
NewThis quarter+3.1%Since filedNew this quarterHeld$25.1M
7.4% of stocks
NewThis quarter-4.1%Since filedNew this quarterHeld$24.5M
7.2% of stocks
NewThis quarter—Since filedNew this quarterHeld$12.3M
3.6% of stocks
+11%This quarter-8.7%Since filed3 qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialAdded 3 qtrs in a row$7.5M
2.2% of stocks
NewThis quarter-4.9%Since filedNew this quarterHeld$4.7M
1.4% of stocks
NewThis quarter-13.5%Since filedNew this quarterHeld
All holdings — Arrowpoint Investment Partners (Singapore) Pte. Ltd. (Q2 2026)
129 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | — CALL | VANECK ETF TRUST - SEMICONDUCTR ETF | — | $52.5M | — | 80K | New | — | — | 13F |
| 12 | SPDR S&P 500 ETF TRUST | — | $29.9M | — | 40K | New | — | — | 13F | |
| 13 | — PUT | ISHARES INC - MSCI STH KOR ETF | — | $17.3M | — | 86K | New | — | — | 13F |
| 14 | — PUT | ISHARES INC - MSCI TAIWAN ETF | — | $12.2M | — | 112K | New | — | — | 13F |
| 15 | — CALL | ISHARES TR - EXPANDED TECH | — | $7.2M | — | 80K | -65% | — | — | 13F |
| 16 | Sandisk Corp | Technology | $4.6M | 1.3% | 2,008 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | ARGENX SEadr | Healthcare | $4.1M | 1.2% | 4,392 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | Infosys Ltdadr | Technology | $3.9M | 1.1% | 367K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | CATERPILLAR INC | Industrials | $3.8M | 1.1% | 3,539 | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Axsome Therapeutics, Inc. | Healthcare | $3.4M | 1.0% | 14K | -16% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | INSMED Inc | Healthcare | $3.2M | 0.9% | 30K | +330% | 3 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | UNITEDHEALTH GROUP INC | Healthcare | $3.2M | 0.9% | 7,657 | +47% | 2 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | BRUKER CORP | Healthcare | $3.2M | 0.9% | 53K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | MADRIGAL PHARMACEUTICALS, INC. | Healthcare | $3.1M | 0.9% | 5,865 | +392% | 4 qtrsAdded 2 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | Travere Therapeutics, Inc. | Healthcare | $3.1M | 0.9% | 55K | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $HUM | HUMANA INC | Healthcare | $3.1M | 0.9% | 7,839 | New | |||
| 27 | $LLY | ELI LILLY & Co | Healthcare | $3.1M | 0.9% | 2,548 | +476% | |||
| 28 | $RVTY | REVVITY, INC. | Healthcare | $3.0M | 0.9% | 27K | New | |||
| 29 | $PTCT | PTC THERAPEUTICS, INC. | Healthcare | $3.0M | 0.9% | 37K | -7% | |||
| 30 | $ABBV | AbbVie Inc. | Healthcare | $3.0M | 0.9% | 12K | New | |||
| 31 | $CHE | CHEMED CORP | Healthcare | $3.0M | 0.9% | 6,365 | New | |||
| 32 | — | ISHARES TR - ISHARES SEMICDTR | — | $2.9M | 0.9% | 4,590 | New | |||
| 33 | $A | AGILENT TECHNOLOGIES, INC. | Healthcare | $2.9M | 0.8% | 22K | New | |||
| 34 | $NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $2.8M | 0.8% | 16K | -24% | |||
| 35 | $TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | $2.8M | 0.8% | 82K | +218% | |||
| 36 | $ALAB | Astera Labs, Inc. | Technology | $2.6M | 0.8% | 5,293 | New | |||
| 37 | $COO | COOPER COMPANIES, INC. | Healthcare | $2.5M | 0.7% | 35K | +489% | |||
| 38 | $TWST | Twist Bioscience Corp | Healthcare | $2.1M | 0.6% | 20K | +51% | |||
| 39 | $QCOM | QUALCOMM INC/DE | Technology | $2.1M | 0.6% | 11K | New | |||
| 40 | $ACHC | Acadia Healthcare Company, Inc. | Healthcare | $2.0M | 0.6% | 67K | New | |||
| 41 | $DVA | DAVITA INC. | Healthcare | $1.8M | 0.5% | 8,046 | New | |||
| 42 | $ALNY | ALNYLAM PHARMACEUTICALS, INC. | Healthcare | $1.7M | 0.5% | 5,588 | New | |||
| 43 | $CON | Concentra Group Holdings Parent, Inc. | Healthcare | $1.6M | 0.5% | 53K | New | |||
| 44 | $BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $1.5M | 0.5% | 27K | -44% | |||
| 45 | $BIIB | BIOGEN INC. | Healthcare | $1.5M | 0.4% | 6,838 | +45% | |||
| 46 | $OSCR | Oscar Health, Inc. | Healthcare | $1.5M | 0.4% | 51K | New | |||
| 47 | $LRCX | LAM RESEARCH CORP | Technology | $1.4M | 0.4% | 3,230 | New | |||
| 48 | — | SELECT SECTOR SPDR TR - ST STR CARE ETF | — | $1.4M | 0.4% | 8,600 | New | |||
| 49 | $AVTR | Avantor, Inc. | Healthcare | $1.3M | 0.4% | 131K | New | |||
| 50 | $RMBS | RAMBUS INC | Technology | $1.3M | 0.4% | 9,559 | New | |||
| 51 | — | ISHARES INC - MSCI TAIWAN ETF | — | $1.2M | 0.3% | 11K | -11% | |||
| 52 | $RVMD | Revolution Medicines, Inc. | Healthcare | $1.1M | 0.3% | 6,100 | -23% | |||
| 53 | $MRNA | Moderna, Inc. | Healthcare | $1.0M | 0.3% | 15K | -13% | |||
| 54 | $BBIO | BridgeBio Pharma, Inc. | Healthcare | $1.0M | 0.3% | 13K | +133% | |||
| 55 | $IONS | IONIS PHARMACEUTICALS INC | Healthcare | $978K | 0.3% | 12K | -68% | |||
| 56 | — | SELECT SECTOR SPDR TR - ST STR UTIL ETF | — | $943K | 0.3% | 21K | +27% | |||
| 57 | $IVZ | Invesco Ltd. | Financials | $939K | 0.3% | 3,100 | New | |||
| 58 | $STT | STATE STREET CORP | Financials | $881K | 0.3% | 20K | New | |||
| 59 | $PRAX | Praxis Precision Medicines, Inc. | Healthcare | $824K | 0.2% | 2,461 | -36% | |||
| 60 | $NTRA | Natera, Inc. | Healthcare | $764K | 0.2% | 2,814 | -5% | |||
| 61 | $CYTK | CYTOKINETICS INC | Healthcare | $753K | 0.2% | 8,836 | +20% | |||
| 62 | — | ISHARES TR - 20 YR TR BD ETF | — | $752K | 0.2% | 8,700 | +23% | |||
| 63 | — | SPDR SERIES TRUST - ST STR SP REGBNK | — | $749K | 0.2% | 10K | New | |||
| 64 | $ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | $727K | 0.2% | 29K | New | |||
| 65 | $WDC | WESTERN DIGITAL CORP | Technology | $723K | 0.2% | 1,132 | New | |||
| 66 | — | SPDR SERIES TRUST - ST STR SP HOME | — | $693K | 0.2% | 6,000 | New | |||
| 67 | $BNTX | BioNTech SE | Healthcare | $679K | 0.2% | 7,301 | +6% | |||
| 68 | $LEGN | Legend Biotech Corp | Healthcare | $626K | 0.2% | 22K | New | |||
| 69 | — | SPDR SERIES TRUST - ST STR SP INS | — | $610K | 0.2% | 10K | New | |||
| 70 | $ORKA | Oruka Therapeutics, Inc. | Healthcare | $601K | 0.2% | 6,315 | +23% | |||
| 71 | — | FRANKLIN TEMPLETON ETF TR - FTSE TAIWAN | — | $591K | 0.2% | 5,600 | +51% | |||
| 72 | $UTHR | UNITED THERAPEUTICS Corp | Healthcare | $561K | 0.2% | 1,035 | +96% | |||
| 73 | — | SELECT SECTOR SPDR TR - ST STR FINL ETF | — | $515K | 0.1% | 9,600 | +55% | |||
| 74 | — | SELECT SECTOR SPDR TR - ST STR TECHN ETF | — | $495K | 0.1% | 2,600 | +1200% | |||
| 75 | $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Healthcare | $442K | 0.1% | 5,427 | New | |||
| 76 | $MRVL | Marvell Technology, Inc. | Technology | $439K | 0.1% | 1,474 | New | |||
| 77 | $ALMS | ALUMIS INC. | Healthcare | $433K | 0.1% | 15K | +28% | |||
| 78 | $ILMN | ILLUMINA, INC. | Healthcare | $416K | 0.1% | 2,368 | -22% | |||
| 79 | $PTGX | Protagonist Therapeutics, Inc | Healthcare | $404K | 0.1% | 3,298 | -65% | |||
| 80 | $AVR | Anteris Technologies Global Corp. | Healthcare | $386K | 0.1% | 39K | New | |||
| 81 | $COGT | Cogent Biosciences, Inc. | Healthcare | $375K | 0.1% | 9,698 | -30% | |||
| 82 | $HPE | Hewlett Packard Enterprise Co | Technology | $370K | 0.1% | 8,193 | New | |||
| 83 | $CERT | Certara, Inc. | Technology | $356K | 0.1% | 54K | New | |||
| 84 | $IMVT | Immunovant, Inc. | Healthcare | $348K | 0.1% | 9,043 | New | |||
| 85 | $MCHP | MICROCHIP TECHNOLOGY INC | Technology | $345K | 0.1% | 3,782 | -100% | |||
| 86 | $RARE | Ultragenyx Pharmaceutical Inc. | Healthcare | $328K | 0.1% | 9,829 | New | |||
| 87 | $BLFS | BIOLIFE SOLUTIONS INC | Healthcare | $328K | 0.1% | 12K | New | |||
| 88 | $ADPT | Adaptive Biotechnologies Corp | Healthcare | $325K | 0.1% | 15K | New | |||
| 89 | $MRVI | MARAVAI LIFESCIENCES HOLDINGS, INC. | Healthcare | $316K | 0.1% | 51K | New | |||
| 90 | $CYRX | Cryoport, Inc. | Healthcare | $315K | 0.1% | 20K | New | |||
| 91 | $BLTE | BELITE BIO, INC | Healthcare | $309K | 0.1% | 2,008 | -67% | |||
| 92 | $TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | Technology | $306K | 0.1% | 640 | New | |||
| 93 | $TXG | 10x Genomics, Inc. | Healthcare | $296K | 0.1% | 7,725 | New | |||
| 94 | $SNDX | Syndax Pharmaceuticals Inc | Healthcare | $279K | 0.1% | 13K | New | |||
| 95 | $YUMC | Yum China Holdings, Inc. | Consumer Discretionary | $265K | 0.1% | 6,473 | New | |||
| 96 | $MLTX | MoonLake Immunotherapeutics | Healthcare | $263K | 0.1% | 13K | New | |||
| 97 | $BIOA | BioAge Labs, Inc. | Healthcare | $257K | 0.1% | 10K | -50% | |||
| 98 | $ACI | Albertsons Companies, Inc. | Consumer Staples | $253K | 0.1% | 19K | New | |||
| 99 | $GPCR | Structure Therapeutics Inc. | Healthcare | $249K | 0.1% | 4,645 | +11% | |||
| 100 | $TNGX | Tango Therapeutics, Inc. | Healthcare | $239K | 0.1% | 7,658 | -63% | |||
| 101 | $ABSI | Absci Corp | Healthcare | $228K | 0.1% | 20K | New | |||
| 102 | $ELVN | Enliven Therapeutics, Inc. | Healthcare | $228K | 0.1% | 4,499 | New | |||
| 103 | $CRVS | Corvus Pharmaceuticals, Inc. | Healthcare | $226K | 0.1% | 15K | New | |||
| 104 | $CAPR | CAPRICOR THERAPEUTICS, INC. | Healthcare | $225K | 0.1% | 9,342 | New | |||
| 105 | $MAZE | Maze Therapeutics, Inc. | Healthcare | $223K | 0.1% | 7,465 | New | |||
| 106 | $CME | CME GROUP INC. | Financials | $221K | 0.1% | 1,003 | New | |||
| 107 | $BE | Bloom Energy Corp | Technology | $221K | 0.1% | 729 | New | |||
| 108 | $MA | Mastercard Inc | Financials | $213K | 0.1% | 415 | New | |||
| 109 | $ABCL | AbCellera Biologics Inc. | Healthcare | $213K | 0.1% | 27K | New | |||
| 110 | $CSGP | COSTAR GROUP, INC. | Industrials | $210K | 0.1% | 7,425 | New | |||
| 111 | $OTIS | Otis Worldwide Corp | Industrials | $208K | 0.1% | 2,903 | New | |||
| 112 | $MLYS | Mineralys Therapeutics, Inc. | Healthcare | $206K | 0.1% | 7,633 | New | |||
| 113 | $CLYM | Climb Bio, Inc. | Healthcare | $199K | 0.1% | 15K | -38% | |||
| 114 | $SLN | Silence Therapeutics plc | Healthcare | $179K | 0.1% | 16K | New | |||
| 115 | $TAL | TAL Education Group | Consumer Discretionary | $155K | 0.1% | 16K | New | |||
| 116 | $CLF | CLEVELAND-CLIFFS INC. | Materials | $124K | 0.0% | 13K | New | |||
| 117 | $LUMN | Lumen Technologies, Inc. | Communication Services | $92K | 0.0% | 12K | New | |||
| 118 | $SNAP | Snap Inc | Technology | $90K | 0.0% | 20K | New | |||
| 119 | $NWL | NEWELL BRANDS INC. | Materials | $90K | 0.0% | 15K | New | |||
| 120 | $PLUG | PLUG POWER INC | Technology | $76K | 0.0% | 28K | +151% | |||
| 121 | — | SELECT SECTOR SPDR TR - ST STR INDL ETF | — | $74K | 0.0% | 400 | -88% | |||
| 122 | $JBLU | JETBLUE AIRWAYS CORP | Industrials | $73K | 0.0% | 13K | New | |||
| 123 | $AMC | AMC ENTERTAINMENT HOLDINGS, INC. | Communication Services | $71K | 0.0% | 37K | New | |||
| 124 | $KOS | Kosmos Energy Ltd. | Energy | $60K | 0.0% | 28K | New | |||
| 125 | $CCC | CCC Intelligent Solutions Holdings Inc. | Technology | $57K | 0.0% | 11K | New | |||
| 126 | $BDN | BRANDYWINE REALTY TRUST | Real Estate | $52K | 0.0% | 16K | +53% | |||
| 127 | $SOC | Sable Offshore Corp. | Energy | $51K | 0.0% | 16K | New | |||
| 128 | $XRX | Xerox Holdings Corp | Technology | $41K | 0.0% | 13K | New | |||
| 129 | — | SELECT SECTOR SPDR TR - ST STR STAPL ETF | — | $25K | 0.0% | 300 | -95% |
What changed in Q2 2026
Against the previous quarter's 13F: 85 new, 23 added to, 21 trimmed, 37 sold out. Share-count changes; largest moves by dollar size first.
New positions (85)
- CALLVANECK ETF TRUST - SEMICONDUCTR ETF$52.5M
first bought this quarter
first bought this quarter
first bought this quarter
$SPYCALLSPDR S&P 500 ETF TRUST$29.9M
first bought this quarter
first bought this quarter
first bought this quarter
+79 more in the Excel export
Added to (23)
$LLYELI LILLY & Co+476%
now $3.1M · held 3 qtrs
now $3.1M · held 4 qtrs, 2 adds in a row
now $3.2M · held 3 qtrs
$COOCOOPER COMPANIES, INC.+489%
now $2.5M · held 3 qtrs
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD+218%
now $2.8M · held 3 qtrs
now $12.3M · held 3 qtrs, 3 adds in a row
+17 more in the Excel export
Trimmed (21)
$MCHPMICROCHIP TECHNOLOGY INC-100%
now $345K · held 2 qtrs
- CALLISHARES TR - EXPANDED TECH-65%
now $7.2M
$IONSIONIS PHARMACEUTICALS INC-68%
now $978K · held 4 qtrs
$BMRNBIOMARIN PHARMACEUTICAL INC-44%
now $1.5M · held 2 qtrs
$NBIXNEUROCRINE BIOSCIENCES INC-24%
now $2.8M · held 3 qtrs
$PTGXProtagonist Therapeutics, Inc-65%
now $404K · held 2 qtrs
+15 more in the Excel export
Holdings by quarter
Every 13F Arrowpoint Investment Partners (Singapore) Pte. Ltd. has filed, 6 earlier quarters. Pick one to see what it held then.
Is it too late to follow Arrowpoint Investment Partners (Singapore) Pte. Ltd.?
Q2 2026 13F filed with the SEC on Aug 13, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s top 20 holdings: 67/100 (our AI quality score, weighted by position size; 18 of the 20 are scored)
Top 10 since filing
-7.8%
Value-weighted move of the 10 largest stock positions
Turnover
83%
Last quarter; 193% over the last 4
Top 10 weight
64%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
3%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q4 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Arrowpoint Investment Partners (Singapore) Pte. Ltd. disclosed 129 positions worth $459.0M in its Form 13F-HR for Q2 2026 — $339.9M in common stock plus $119.1M of put/call option positions (reported at underlying notional value, not premium at risk), led by $C (CITIGROUP INC) at 9.7% of the equity portfolio, followed by $GS and $GPN. During the quarter the fund opened 85 new positions and exited 37. The portfolio is most concentrated in Financials (27.8% of disclosed assets). All figures are sourced directly from Arrowpoint Investment Partners (Singapore) Pte. Ltd.’s Form 13F-HR filing with the SEC under CIK 2032331.
Funds like this
managers whose biggest positions overlap Arrowpoint Investment Partners (Singapore) Pte. Ltd.'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Arrowpoint Investment Partners (Singapore) Pte. Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Arrowpoint Investment Partners (Singapore) Pte. Ltd. (SEC CIK: 2032331), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Arrowpoint Investment Partners (Singapore) Pte. Ltd.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.